Next Article in Journal
Pretreatment Modified Albumin–Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular Carcinoma
Previous Article in Journal
Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?
 
 
Case Report

Article Versions Notes

Curr. Oncol. 2022, 29(7), 4791-4798; https://doi.org/10.3390/curroncol29070380
Action Date Notes Link
article pdf uploaded. 7 July 2022 14:14 CEST Version of Record https://www.mdpi.com/1718-7729/29/7/380/pdf-vor
article xml file uploaded 11 July 2022 10:45 CEST Original file -
article xml uploaded. 11 July 2022 10:45 CEST Update https://www.mdpi.com/1718-7729/29/7/380/xml
article pdf uploaded. 11 July 2022 10:45 CEST Updated version of record https://www.mdpi.com/1718-7729/29/7/380/pdf
article html file updated 11 July 2022 10:46 CEST Original file -
article html file updated 13 August 2022 00:40 CEST Update -
article html file updated 10 September 2025 19:44 CEST Update https://www.mdpi.com/1718-7729/29/7/380/html
Back to TopTop